Surgery to make men taller: what it adds and who should skip it

The literature is consistent. Marwan and colleagues pooled 11 cosmetic-lengthening studies, 795 patients in all: 520 men and 275 women, a 1.6-to-1 ratio, mean age 26.1, range 14 to 68. The one large series that bucks the trend is Russian. Novikov's 131 Ilizarov patients in Kurgan, treated between 1983 and 2006, were 65 men and 66 women, a reminder that the male tilt is not universal.

Who wants height surgery for men? Lari and Alherz surveyed 383 adults in 2024. Of the 27 who said they would consider stature lengthening, 20 (74.1%) were men. Those men averaged 171 cm, against 178 cm for the men who were not interested, a 7 cm gap the authors report as statistically significant, and 18 of the 27 (66.7%) described themselves as short. The pull factors they named were the range of height increase, social benefits and success rates. The push-backs were complications, weight-bearing restrictions and cost.

Demand for leg lengthening surgery for men is rising in the United States. NBC News reported in April 2023 that Dr. Shahab Mahboubian in Los Angeles expected to perform 50 stature-lengthening operations that year, up from 20 three years earlier, and that he sees patients in their 60s. The patient NBC profiled, Alex, 26, went from 5 ft 7 in to 5 ft 10 in for roughly $75,000 plus $10,000 for rod removal. His stated reason was being tired of jokes about a trait he could not control.

One femur stage adds up to 8 cm. That is the cap at Hospital for Special Surgery and at the Paley Institute, and the International Center for Limb Lengthening (ICLL) in Baltimore recommends 5 to 8 cm. A tibia stage adds about 5 cm at Paley; HSS quotes another 2 to 3 inches. Done a year apart, the two stages reach roughly 13 cm, and both HSS and the ICLL give 5 to 6 inches as the two-stage total.

The averages sit below the caps. Across the 795 pooled patients the mean gain was 6.7 cm, with a range of 1.5 to 13.0 cm. In Novikov's 131 frame patients the mean was 6.9 cm; men gained 7.3 cm and women 6.5 cm.

Both femurs are lengthened in one operation with two magnetic nails, one per bone, and the nail is extended by less than 1 mm a day with an external magnet. The tibias are a separate admission, usually a year later, and the femoral nails come out at about 12 months. See the PRECICE 2 method page for how the magnet works and the LON page for the cheaper hybrid used in Turkey and India.

What you cannot buy is 6 inches in one surgery. Nerve and muscle tolerance limits each segment, which is why every serious center sells 6 inches as two stages and two recoveries. Our guide to how much taller limb lengthening realistically makes you covers the proportion arithmetic.

It hurts in three phases, and the phases feel different. The first days after the bone cuts are the sharpest; HSS describes it as initial pain that is generally well tolerated with medication. The daily lengthening is not the sharp part. HSS states that lengthening is usually not painful because it happens slowly, and the ICLL says most people feel nothing when the magnet is applied. What men describe instead is a deep, dragging ache in the thigh that builds through the distraction weeks as muscle, fascia and nerve are stretched a millimeter a day. Our phase-by-phase pain guide puts the peak around weeks four to eight.

The third phase is physiotherapy, and it lasts longest. HSS requires daily stretching during lengthening to prevent stiffness; the NBC patient went four to five times a week for four months, first on a walker, then a cane. Skipping it is how contractures happen. In Novikov's 131 frame patients, 14 (11%) developed a fixed knee-flexion deformity and 12 (9%) an equinus ankle. In the 314-nail Frost cohort, contracture accounted for 51 of the 72 joint complications.

Nerve pain is the one to report, not endure. Common peroneal neuropathy occurred in 6 of 131 (4.6%) Kurgan patients. Burning or shooting pain down the shin or into the foot means the distraction rate may need to slow, and only the operating surgeon can make that call.

Yes, and the honest way to say how risky is with the sample size attached. Novikov et al., 2014: 131 cosmetic Ilizarov patients, 48 (37%) had at least one complication, 59 complications in total, 28% soft-tissue and 17% bone. Frost et al., 2023: 314 FITBONE and PRECICE nails in 257 patients, 22% of segments for short stature, and 144 patients (53%) had a complication; device-related problems were the most frequent category, joint contracture next. Marwan's 2020 review of 795 cosmetic patients recorded 0.15 complications per patient and concluded that the rate of serious major complications was low; problems and obstacles, the things fixed without a new operation, were far more common at 0.78 and 0.94 per patient.

The ICLL's own risk list for cosmetic candidates: nonunion, leg-length discrepancy, nerve stretch injury, muscle contracture, joint arthritis, deep-vein thrombosis and fat embolism. Add device failure and reoperation from the nail series.

Three things move your personal number. Age: in the Frost cohort, being over 30 roughly doubled complication risk compared with 10-to-19-year-olds (adjusted relative risk 1.9 to 2.6). Segment: tibias carried 1.7 times the risk of femurs. Indication: short-stature cases had 1.8 times the risk of the reference group. A 24-year-old doing femurs with a high-volume surgeon and a 42-year-old doing tibias are not taking the same bet. The 2026 safety review goes through each complication class in detail.

The country sets the price, not the device. The table lists what clinics themselves publish, as recorded in our directory in 2026 and re-checked on the Paley and HSS pages this month. Every row has a scope: which segment, which device, what the package includes. Where a clinic publishes in euros or won, the dollar figure is a conversion and will drift.

Two cautions. First, the package is not the total. Hardware removal at HSS and Paley is billed separately, $18,000 for femurs at Paley; physiotherapy, medication and lodging are excluded at HSS; and a complication is on you. The ICLL states plainly that cosmetic lengthening is not covered by medical insurance and that any additional surgery or treatment for complications is the patient's responsibility.

Second, cheap and expensive buy the same nail. The cost guide explains why a femur stage priced at $125,000 at HSS is quoted at $16,000 to $55,000 in India: operating-room overhead, surgeon fees and legal exposure, not hardware. What to verify before wiring a deposit is the named operating surgeon, the hospital, and the removal price in writing.

Plan the calendar around three sourced milestones. Hospital: about three days at the ICLL, one or two nights at HSS. Lengthening: three to four months for femurs, during which the ICLL sees you every 10 to 14 days for X-rays, HSS wants daily stretching, and the NBC patient did physiotherapy four to five times a week on a walker. Function: HSS says most patients return to their desired activities at six months; the ICLL says full recovery including sport can take one or even two years. Our recovery handbook puts unaided walking at four to six months.

Translate that into work. Nothing in the published protocols prevents seated laptop work once you are home; what limits it is fatigue, pain medication and the daily physio block, so a desk job can often restart on a reduced schedule within weeks. Many international patients spend the whole lengthening phase near the clinic, which is why the Gurgaon package above bundles three months of accommodation and the Istanbul package bundles hotel or home stays. A job that requires standing, lifting, driving or travel is realistically off the table for four to six months, and the tibia stage a year later repeats most of that. Nail removal at about 12 months is a shorter admission, but still time off.

The number to negotiate with an employer is therefore not two weeks. It is a three-to-four-month reduced-capacity block, then a second one the following year if you want the tibias too.

Men do not buy 7 cm of femur for the femur. In the Lari survey, social benefits was one of the three reasons respondents gave for considering surgery, and the NBC patient's motive was the jokes.

Attractiveness research points at proportion, not just height. Sorokowski and colleagues had 3,103 people in 27 nations rate silhouettes that varied in leg-to-body ratio. Silhouettes with short legs and silhouettes with excessively long legs were both rated less attractive, in every nation studied. Lengthening changes exactly that ratio. A single femur stage moves it modestly; stacking a maximal tibia stage on top moves it much further, which is why the target should be modeled, not guessed. Run your numbers through the proportion calculator before you choose a target, not after.

Satisfaction data are good and easy to misread. Novikov reported that 130 of 131 patients felt satisfied and had improved self-esteem. But satisfaction with the operation is not the same as the distress being gone. In Crerand's series of 200 people with body dysmorphic disorder, cosmetic procedures improved overall BDD severity after only 2.3% of treatments, even where preoccupation with the treated body part fell. If your distress is out of proportion to a measured 171 cm, the evidence-based first step is an assessment, not an osteotomy. The psychology of height surgery explains how clinics screen and why the ICLL asks for candidates who are psychologically stable and have their family's support.

1. Open growth plates. The ICLL requires complete skeletal maturity and HSS wants closed plates on X-ray. For men that usually means 18 to 21; the age-limit guide has the detail.

2. An untreated body-image disorder. With a 2.3% improvement rate for BDD after cosmetic procedures, surgery is the wrong first tool, and the ICLL lists psychological stability as a candidacy requirement.

3. A budget with no reserve. The ICLL is explicit that complications, including additional surgery, are the patient's cost. If the package price is your whole budget, you cannot afford the operation.

4. Expecting 6 inches in one go. No center offers it in one stage. The two-stage plan is two recoveries and two bills.

5. Uncontrolled joint disease, deformity or infection. HSS requires large deformities such as bowleg or knock knee, infections and joint pain to be managed before stature lengthening.

6. A job or life that cannot pause for four to six months, twice.

7. Age over about 30 without accepting the trade. The Frost cohort roughly doubled complication risk past 30. It is not a ban, but the consent conversation is different.

8. No named surgeon. If the quote comes from a coordinator and you cannot find the operating surgeon's name, registration and case series, walk away. Our directory of leg lengthening surgeons lists who actually operates and where.

Surgery to make men taller exists, works, and is measured in centimeters rather than in wishes. One femur stage: 5 to 8 cm, about a year from operation to nail removal, a one-in-three to one-in-two chance of some complication, most of them fixable, and $16,000 to $125,000 depending on country. Two stages: about 13 cm, two years, two budgets. Two-thirds of the people who do it are men, the pooled mean age is 26, and most report satisfaction afterward.

The complication series point the same way: risk rises with tibias and with age, and every extra segment repeats the same list of risks. So do not buy a number. Buy a plan: a femur stage inside the 8 cm cap, a surgeon you can name and check, a country whose price you can survive with a complication added, and a psychological assessment done before the deposit rather than after. Start with What is height surgery?, then the cost guide, then the surgeon directory. Surgery to make men taller is a plan with numbers, or it is a mistake with a bill.